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A B S T R A C T
Spin-lattice relaxation in the rotating framemagnetic resonance imaging allows for the quan-
titative assessment of spin-lock contrast within tissues. We describe the utility of spin-
lattice relaxation in the rotating frame metrics in characterizing glioblastoma biological
heterogeneity. A 84-year-old man presented to our institution with a right frontal tempo-
ral mass. Prior tissue sampling from a peripheral nonenhancing lesion was nondiagnostic.
Stereotactic image-guided tissue sampling of the nonenhancing T2-fluid-attenuated inver-
sion recovery hyperintense region involving the anterior cingulate gyrus with elevated spin-
lattice relaxation in the rotating framemetrics provided a pathologic diagnosis of glioblastoma.
This case illustrates the utility of spin-lattice relaxation in the rotating frame magnetic res-
onance imaging in identifying biologically aggressive regions within glioblastoma.
© 2017 the Authors. Published by Elsevier Inc. under copyright license from the University
ofWashington. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Glioma is the most common supratentorial brain tumor af-
fecting approximately 138,000 individuals in the United States
in 2010, with an annual incidence of 17,000 new cases [1].
Despite significant advances in surgical, radiation, and medical
therapies, the prognosis of this disease remains dismal, with
a median survival of less than 2 years for the most malig-
nant form, glioblastoma [2]. A number of biological, clinical,
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and diagnostic factors account for the poor prognostic out-
comes of patients with glioma. One factor that directly impacts
the diagnosis of glioma is tumoral biological heterogeneity.
The pathologic assessment of glioma relies on an invasive
procedure for tissue sampling that is often performed without
regard for tumor biological heterogeneity. The assessment of
tumor aggressiveness based on isolated regional tissue samples
can lead to sampling error, resulting in undergrading, with a
published report in up to 30% of cases [3,4]. The inherent limi-
tations of histologic techniques to assess tumor grade have led
to the development of imaging-based methods for the non-
invasive quantification of aggressive biological characteristics.
Recent advances inmagnetic resonance imaging (MRI) have
provided for the acquisition of physiological metrics with the
potential to noninvasively assess biological characteristics that
influence the tumor grade and the clinical prognosis of pa-
tientswith glioma.ThesephysiologicalMRI sequences contribute
data that complement the standard information provided by
traditional morphologicT1- andT2-weighted techniques. One
recently developed physiological sequence is spin-lattice re-
laxation in the rotating frame (T1ρ). T1ρ allows for the
quantitative assessment of spin-lock contrast within tissues
[5].Aronen et al. have previously published a case series ofT1ρ
imaging obtained at 0.1-T field strength in a cohort of 11 pa-
tients with high-grade glioma and concluded that spin-lock
contrast maps have the potential to improve tissue biological
characterization.Therefore, the specific aim of this case report
was to describe our initial experience with the use of T1ρ MRI
in characterizing glioblastoma biological heterogeneity.
Case report
An 84-year-old man presented to our institution on April 2014
with a right frontal temporal mass lesion (Fig. 1). Relevant past
medical history included adenocarcinoma of the left lung, for
which the patient had undergone lobectomy on August 2013.
On September 2013, the patient experienced a brief episode
of vertigo that resulted in a fall from standing. MRI of the brain
demonstrated a nonenhancing T2 hyperintense mass cen-
tered within the right frontal operculumwith regional extension
including the anterior cingulate gyrus. The patient under-
went a short-interval follow-up MRI on October 2013 that was
unchanged. Imaging on March 2014 demonstrated a progres-
sion of a presumed, but not pathologically confirmed, glioma
evidenced by focal contrast enhancement, now within the
orbitofrontal gyri. At another institution, the patient under-
went burr hole tissue sampling from within the peripheral
nonenhancingmargin involving the superior frontal gyrus white
matter.The lack of infiltrative tumor cells resulted in the sample
being classified as nondiagnostic (Fig. 2, center left image).
OnApril 2014, the patient presented to our institution’s Neu-
rological Surgery service for image-guided tissue sampling and
subsequent therapy. Standard preoperative MRI using a 3.0-T
scanner (Discovery; GE Healthcare, Waukesha, WI) was ob-
tained 24 hours before the tissue sampling procedure ([6–8]; Fig. 1
and Fig. 2).
A magnetization-prepared 3-dimensional pseudo–steady-
state fast spin-echo acquisition pulse sequence was used for
T1ρ quantification. T1ρ imaging parameters included
0.9 × 0.9 × 1.6 mm resolution, 280 × 196 mm field of view, 120
slices, 0.5 number of excitations, 2× Autocalibrating Recon-
struction for Cartesian parallel imaging (GE Healthcare) along
the phase encoding direction, an echo train length of 132, a
spin-lock frequency of 500 Hz, and a time of spin lock of 2, 10,
40, 60, 80, and 100 ms. The total scan time for T1ρ data acqui-
sition was 3.5 minutes.T1ρ imaging was performed before the
intravenous administration of 0.1 mmol/kg gadopentetate
dimeglumine (Gd-DTPA; Magnevist, Bayer HealthCare
Pharmaceuticals).
T1ρ image processing was performed offline using a com-
mercially available postprocessing workstation (Advantage
Workstation, GE Healthcare) and software (FuncTool 9.4.05a,
GE Healthcare), allowing for the generation of quantitative
whole-brain spin-lock contrast maps (Fig. 1 and Fig. 2) that could
Fig. 1 – Preoperative MRI of a right frontal temporal mass lesion. An 84-year-old man presented to our institution with a T2/
FLAIR hyperintense mass (left image) within the right frontal operculum with extension into the right subinsular white
matter, anterior cingulate, right anterior temporal, and mesotemporal lobes. Focal contrast enhancement (center left image)
was observed within the right cingulate gyrus. Despite the patient’s past medical history of lung adenocarcinoma, the
morphologic appearance of the mass was believed to be likely due to a high-grade primary glial neoplasm. T1ρ MRI (center
right image) demonstrates heterogeneous spin-lock contrast values within the enhancing and nonenhancing tumor
components. Fused T1ρ and T1-weighted postcontrast image (right image) demonstrates a focal region of markedly
elevated T1ρ within a nonenhancing tumor component (arrow). MRI, magnetic resonance imaging.
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be integrated into the stereotactic image-guided procedure
(Brainlab, VectorVision Navigation System).
Anatomic and physiological MRI was used to guide the
prospective selection of tissue sampling sites felt most likely
to represent a bulk tumor that would allow for a definitive
diagnosis of disease etiology. Two sampling sites were preop-
eratively planned utilizing the surgical navigation workstation
(Brainlab, VectorVision Navigation System). Criteria used to
plan sites were based upon results from previous studies as
having either a relative cerebral blood volume of >3, an
apparent diffusion coefficient of <1200, and a Cho to N-acetyl
aspartate index of >2.0; however, this provided for only a
target within the subinsular white matter that was not
radially accessible by a right transfrontal stereotactic ap-
proach [8,9]. Tissue sampling was performed as close to the
target of interest yielding a single diagnostic sample (Fig. 3).
A retrospective evaluation of the T1ρ map demonstrated a
nonenhancing region within the anterior cingulate with mark-
edly elevated spin-lock contrast metrics (T1ρmin = 110,
T1ρmean = 244, T1ρmax = 352) above background normal-
appearing white matter (NAWM; T1ρmin = 62, T1ρmean = 89,
T1ρmax = 126). Relative T1ρ values within the anterior cingu-
late gyrus were calculated as the ratio of the lesion to the
NAWM (rT1ρmin = 1.77, rT1ρmean = 2.74, rT1ρmax = 2.79).
Fig. 2 – Site of nondiagnostic tissue sampling demonstrates a minimally increased T1ρ. Stereotactic magnetic resonance-
guided tissue sampling (arrows) from a nonenhancing (left) T2-fluid-attenuated inversion recovery hyperintense (center
left) component of the mass within the superior frontal gyrus white matter 1 month prior yielded a nondiagnostic
pathologic result. T1ρ magnetic resonance imaging (center right) demonstrated fairly homogenous, minimally elevated,
spin-lock contrast values. Fused (right) T1ρ and fluid-attenuated inversion recovery weighted imaging shows the previously
sampled portion of the tumor is from within a region of minimally elevated T1ρ when compared to the contralateral
normal-appearing white matter.
Fig. 3 – Image-guided tissue sampling of a nonenhancing focus provides a pathologic diagnosis of glioblastoma.
Intraoperative screenshot obtained at the time of magnetic resonance-guided tissue sampling from a nonenhancing
component of the tumor within the anterior cingulate gyrus demonstrates the location of the diagnostic tissue specimen
(purple bars centered in cross hair).
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Interrogation of the T2 hyperintense nonenhancing white
matter adjacent to the prior nondiagnostic tissue sampling
site within the right superior frontal gyrus demonstrated
lesion T1ρ values (T1ρmin = 102, T1ρmean = 126, T1ρmax = 165)
that were only mildly elevated with respect to NAWM
(T1ρmin = 59, T1ρmean = 85, T1ρmax = 122) (Fig. 2). This finding
provided for rT1ρ values that were less than the similar-
appearing nonenhancing T2 hyperintense lesion within the
anterior cingulate gyrus (rT1ρmin = 1.73, rT1ρmean = 1.48,
rT1ρmax = 1.35) (Fig. 4).
Intraoperative stereotactic magnetic resonance-guided tissue
sampling of the nonenhancing T2-fluid-attenuated inversion
recovery hyperintense region involving the anterior cingu-
late gyrus with elevated T1ρ metrics provided a pathologic
diagnosis of glioblastoma with a Ki-67 score of 40% (Fig. 5).
Given the high diagnostic yield of this tissue sample, no
additional samples were obtained. The patient subsequently
recovered well from the procedure and was discharged on
postoperative day 5. Surgical debulking of the tumor was not
performed because of the extent and the location of the
disease. The patient is currently undergoing radiotherapy
(2 Gy/day, 5 days/week for 6 weeks, total dose of 60 Gy) and
temozolomide-based medical therapy (75 mg/m2/day for 42
days followed by 150 mg/m2/day for 5 consecutive days over
28 days for 6 cycles).
Discussion
This case report highlights our initial experience in using T1ρ
MRI to differentiate similar-appearing nonenhancing regions
of T2 hyperintensity caused by a biologically aggressive glio-
blastoma from regions of non–tumor infiltrated vasogenic
edema. The nonenhancing tissue sampling site comprising
vasogenic edema without tumor demonstratedT1ρ values that
were only slightly elevated from NAWM (Fig. 3). Conversely, the
nonenhancing tissue sampling site comprising glioblastoma
had mean and maximumT1ρ values almost 3fold higher than
NAWM. To our knowledge, this is the first report of T1ρ MRI
directly characterizing an aggressive biological process het-
erogeneously occurring within a patient with glioblastoma.We
provide pathologic confirmation that T1ρ imaging differs re-
gionally within glioblastoma when compared to reactive white
matter changes resulting from vasogenic edema.
Fig. 4 – Fusion of T1ρ and morphologic magnetic resonance imaging allows for spin-lock contrast quantification. Fusion of
the region of interest (purple bars) placed on a T1ρ spin-lock contrast map that has been fused to T2 (left) and T1
postcontrast (right) images allows for quantification of T1ρ metrics within the nonenhancing tissue sampling sites from
diagnostic (top) and nondiagnostic (bottom) regions.
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T1ρ was initially described within solid-state materials by
Redfield [10,11]. To date, clinical applications of this MRI tech-
nique has beenmost widely applied to evaluating the hydration
status of human articular cartilage. However, the neurologic
applications of T1ρ MRI have been explored in patients with
ischemia, neurodegenerative disorders, and brain tumors, and
as a response assessment to gene therapy within gliomamouse
models [12–23]. T1ρ MRI obtains tissue contrast through the
quantification of spin-lattice relaxation in the rotating frame.
This technique allows for the measurement of low-frequency
processes at clinical MRI field strengths [24,25]. This measure-
ment is achieved by first flipping the spin magnetization into
the transverse plane by a 90° radiofrequency pulse. Next, a spin-
lock pulse (low-powered B1 radiofrequency pulse) is applied
parallel to the magnetic moment. The spin-locked magneti-
zation then relaxes with a time constant T1ρ during the
application of the spin-lock pulse.T1ρ dispersion is then mea-
sured by varying the B1 field amplitude within a constant Bo
field. This technique allows for the measurement of spin in-
teraction and motional processes that occur at very low
frequency components (100 Hz to a few kilohertz).
The biological etiology of differential T1ρ relaxation within
glioma has not been fully adjudicated; however, proton chem-
ical exchange (pH), dipole-dipole interactions, spin-spin
coupling, diffusion, and slow rotational motions of spins on
large macromolecules have been postulated to contribute in
various degrees [26]. Histologically, within cartilage speci-
mens, variation in theT1ρ relaxation is hypothesized primarily
to be due to the hydration status and the interaction between
the restricted water pool and the free water pool [27].
Within glioma, we hypothesize that variation in T1ρ relax-
ation is similarly related to the interaction between free and
bound water molecules. The observation of elevated T1ρ as-
sociated with biologically aggressive glioblastoma tissues may
be multifactorial; however, a predominating factor may be due
to the degree of vasogenic edema. Within glioblastoma, a
hypoxia-mediated vascular endothelial growth factor expres-
sion has been shown to upregulate neovascularization [28].This
results in deregulated angiogenesis, endothelial prolifera-
tion, and increased capillary permeability.The increase in local
capillary endothelial permeability results in an immediate in-
crease in the interstitial nutrient supply that facilitates tumor
growth. However, this also results in interstitial hydration
(vasogenic edema) manifested byT2/FLAIR prolongation onMRI.
The tissue contrast provided by T1ρ imaging may provide a
quantifiable map of tissue hydration status not possible by
FLAIR or T2-weighted sequences. Future applications of T1ρ
imaging could include reducing tissue sampling error and
undergrading within nonenhancing gliomas.
The observations of this case report are inherently limited.
Further prospective studies adjudicating the biological influ-
ences and clinical significance ofT1ρ MRI in patients diagnosed
with glioma are needed. One possible obstacle to overcomewith
T1ρ imaging is its propensity to cause tissue heating. Prior
studies have suggested the high specific absorption rate that
occurs during prolonged spin-lock pulses may be an impedi-
ment to the widespread clinical application of T1ρ MRI [29,30].
We have decreased the likelihood of tissue heating by limit-
ing the spin-lock time to a maximum of 100 ms.
Conclusion
The observations of this case report suggest that it is feasible
to integrate T1ρ MRI into the clinical evaluation for biologi-
cally aggressive regions within glioblastomas.
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